Company page
Immuron Limited
Immuron Limited is a public company traded on the Australian market under the ticker IMC. The company has a market capitalization of approximately AUD 8.55 million. Immuron focuses on developing therapies for various health conditions, leveraging its proprietary technology and research.
- Ticker
- IMC:ASX
- Asset type
- Stock
- Market cap
- $13.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD